Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Kenneth Galbraith

CEO, Chair at Zymeworks Inc. (ZYME)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.3M

Reported trades

Filed Stock Type Shares Price Value Since
Jan 12SEC ZYMEZymeworks Inc. Sell 30,424226,842 held (−12%) $22.67 $690K +10.4%
Jan 5SEC ZYMEZymeworks Inc. Sell 22,657158,286 held (−13%) $25.10 $569K -0.3%
Jan 5SEC ZYMEZymeworks Inc. Sell 31,686193,266 held (−14%) $25.10 $795K -0.3%
Dec 22SEC ZYMEZymeworks Inc. Sell 47,528133,275 held (−26%) $27.02 $1.3M -7.4%
  • Sell

    CEO, Chair Kenneth Galbraith sold $1.3M of ZYME at $27.02 — cuts the stake by 26%.